GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Gross Margin %

Covalon Technologies (TSXV:COV) Gross Margin % : 61.10% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Covalon Technologies's Gross Profit for the three months ended in Dec. 2023 was C$2.85 Mil. Covalon Technologies's Revenue for the three months ended in Dec. 2023 was C$4.66 Mil. Therefore, Covalon Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 61.10%.

Warning Sign:

Covalon Technologies Ltd gross margin has been in long-term decline. The average rate of decline per year is -6.9%.


The historical rank and industry rank for Covalon Technologies's Gross Margin % or its related term are showing as below:

TSXV:COV' s Gross Margin % Range Over the Past 10 Years
Min: 34.4   Med: 61.89   Max: 76.94
Current: 53.91


During the past 13 years, the highest Gross Margin % of Covalon Technologies was 76.94%. The lowest was 34.40%. And the median was 61.89%.

TSXV:COV's Gross Margin % is ranked worse than
55.47% of 741 companies
in the Biotechnology industry
Industry Median: 59.43 vs TSXV:COV: 53.91

Covalon Technologies had a gross margin of 61.10% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Covalon Technologies was -6.90% per year.


Covalon Technologies Gross Margin % Historical Data

The historical data trend for Covalon Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Gross Margin % Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.17 34.40 49.57 41.30 54.00

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.74 57.58 57.48 41.93 61.10

Competitive Comparison of Covalon Technologies's Gross Margin %

For the Biotechnology subindustry, Covalon Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Gross Margin % falls into.



Covalon Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Covalon Technologies's Gross Margin for the fiscal year that ended in Sep. 2023 is calculated as

Gross Margin % (A: Sep. 2023 )=Gross Profit (A: Sep. 2023 ) / Revenue (A: Sep. 2023 )
=14.4 / 26.595
=(Revenue - Cost of Goods Sold) / Revenue
=(26.595 - 12.233) / 26.595
=54.00 %

Covalon Technologies's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=2.8 / 4.663
=(Revenue - Cost of Goods Sold) / Revenue
=(4.663 - 1.814) / 4.663
=61.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Covalon Technologies  (TSXV:COV) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Covalon Technologies had a gross margin of 61.10% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Covalon Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (TSXV:COV) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.

Covalon Technologies (TSXV:COV) Headlines

No Headlines